292 related articles for article (PubMed ID: 32380172)
21. Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine.
Barateiro LGRP; de Oliveira Cavagna R; Dos Reis MB; de Paula FE; Teixeira GR; Moreno DA; Bonatelli M; Santana I; Saggioro FP; Neder L; Stavale JN; Malheiros SMF; Garcia-Rivello H; Christiansen S; Nunes S; da Costa MJG; Pinheiro J; Júnior CA; Mançano BM; Reis RM
Neuropathology; 2024 May; ():. PubMed ID: 38736183
[TBL] [Abstract][Full Text] [Related]
22. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Kool M; Korshunov A; Remke M; Jones DT; Schlanstein M; Northcott PA; Cho YJ; Koster J; Schouten-van Meeteren A; van Vuurden D; Clifford SC; Pietsch T; von Bueren AO; Rutkowski S; McCabe M; Collins VP; Bäcklund ML; Haberler C; Bourdeaut F; Delattre O; Doz F; Ellison DW; Gilbertson RJ; Pomeroy SL; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):473-84. PubMed ID: 22358457
[TBL] [Abstract][Full Text] [Related]
23. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
[TBL] [Abstract][Full Text] [Related]
24. Medulloblastoma in a child with osteoma cutis - a rare association due to loss of
Suntharesan J; Lyulcheva-Bennett E; Hart R; Pizer B; Hayden J; Ramakrishnan R
J Pediatr Endocrinol Metab; 2024 May; 37(5):467-471. PubMed ID: 38529810
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
[TBL] [Abstract][Full Text] [Related]
26. The transcriptional landscape of Shh medulloblastoma.
Skowron P; Farooq H; Cavalli FMG; Morrissy AS; Ly M; Hendrikse LD; Wang EY; Djambazian H; Zhu H; Mungall KL; Trinh QM; Zheng T; Dai S; Stucklin ASG; Vladoiu MC; Fong V; Holgado BL; Nor C; Wu X; Abd-Rabbo D; Bérubé P; Wang YC; Luu B; Suarez RA; Rastan A; Gillmor AH; Lee JJY; Zhang XY; Daniels C; Dirks P; Malkin D; Bouffet E; Tabori U; Loukides J; Doz FP; Bourdeaut F; Delattre OO; Masliah-Planchon J; Ayrault O; Kim SK; Meyronet D; Grajkowska WA; Carlotti CG; de Torres C; Mora J; Eberhart CG; Van Meir EG; Kumabe T; French PJ; Kros JM; Jabado N; Lach B; Pollack IF; Hamilton RL; Rao AAN; Giannini C; Olson JM; Bognár L; Klekner A; Zitterbart K; Phillips JJ; Thompson RC; Cooper MK; Rubin JB; Liau LM; Garami M; Hauser P; Li KKW; Ng HK; Poon WS; Yancey Gillespie G; Chan JA; Jung S; McLendon RE; Thompson EM; Zagzag D; Vibhakar R; Ra YS; Garre ML; Schüller U; Shofuda T; Faria CC; López-Aguilar E; Zadeh G; Hui CC; Ramaswamy V; Bailey SD; Jones SJ; Mungall AJ; Moore RA; Calarco JA; Stein LD; Bader GD; Reimand J; Ragoussis J; Weiss WA; Marra MA; Suzuki H; Taylor MD
Nat Commun; 2021 Mar; 12(1):1749. PubMed ID: 33741928
[TBL] [Abstract][Full Text] [Related]
27. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
[TBL] [Abstract][Full Text] [Related]
28. Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
Mitani Y; Fukuoka K; Mori M; Arakawa Y; Matsushita Y; Hibiya Y; Honda S; Kobayashi M; Tanami Y; Kanemura Y; Ichimura K; Nakazawa A; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2021 Jan; 80(2):205-207. PubMed ID: 33367701
[No Abstract] [Full Text] [Related]
29. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
[TBL] [Abstract][Full Text] [Related]
31. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD
Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199
[TBL] [Abstract][Full Text] [Related]
32. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
[TBL] [Abstract][Full Text] [Related]
33. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
Korshunov A; Sahm F; Okonechnikov K; Ryzhova M; Stichel D; Schrimpf D; Casalini B; Sievers P; Meyer J; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol; 2019 Jun; 137(6):1003-1015. PubMed ID: 30826918
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Clinical and Molecular Wnt and SHH Subgroups in Medulloblastoma Tumor Cases.
Kaya IS; Aksoy S; Mutlu M; Tekin C; Taskapilioglu MO; Tunca B; Civan MN; Ocak PE; Kocaeli H; Bekar A; Egeli U; Cecener G; Tolunay S
Turk Neurosurg; 2021; 31(4):554-565. PubMed ID: 33978203
[TBL] [Abstract][Full Text] [Related]
35. Medulloblastoma, macrocephaly, and a pathogenic germline PTEN variant: Cause or coincidence?
Tolonen JP; Hekkala A; Kuismin O; Tuominen H; Suo-Palosaari M; Tynninen O; Niinimäki R
Mol Genet Genomic Med; 2020 Sep; 8(9):e1302. PubMed ID: 32419380
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
[TBL] [Abstract][Full Text] [Related]
37. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
[TBL] [Abstract][Full Text] [Related]
38. Clinical and mutational profiles of adult medulloblastoma groups.
Wong GC; Li KK; Wang WW; Liu AP; Huang QJ; Chan AK; Poon MF; Chung NY; Wong QH; Chen H; Chan DTM; Liu XZ; Mao Y; Zhang ZY; Shi ZF; Ng HK
Acta Neuropathol Commun; 2020 Nov; 8(1):191. PubMed ID: 33172502
[TBL] [Abstract][Full Text] [Related]
39. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.
Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N
Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850
[TBL] [Abstract][Full Text] [Related]
40. Germline
Begemann M; Waszak SM; Robinson GW; Jäger N; Sharma T; Knopp C; Kraft F; Moser O; Mynarek M; Guerrini-Rousseau L; Brugieres L; Varlet P; Pietsch T; Bowers DC; Chintagumpala M; Sahm F; Korbel JO; Rutkowski S; Eggermann T; Gajjar A; Northcott P; Elbracht M; Pfister SM; Kontny U; Kurth I
J Clin Oncol; 2020 Jan; 38(1):43-50. PubMed ID: 31609649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
